FDA Approved: DEFERASIROX — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves a generic version of deferasirox (Zydus Pharmaceuticals USA) under ANDA211383 for chronic iron overload due to blood transfusions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload Due to Transfusion
• Transfusion-dependent Iron Overload

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)